Vtcertificationboard.org

A
AA, see Alcoholics Anonymous
abdominal discomfort, 5-29
abilities, physical, 3-7, 3-29
ability to pay for treatment, 3-28, 8-2 abnormality, 3-28 absorption, 5-10 abstinence, 1-1, 1-13, 1-18, 3-4, 3-16, 5-14, 5-20, 5-22, 5-29, 5-30, accessibility of services, 3-27, 3-28 accidents, 2-18, 2-21, 2-24, 2-27, 3-7, 3-9, 8-5 accountability, 8-7 acculturation, 3-1, 3-6, 3-23 acetaldehyde, 4-6, 5-19, 5-22, 7-11 acetic acid, 4-7 acetylcholine, 5-6 ACOA, see Adult Children of Alcoholism Acquired Immuno-Deficiency Syndrome (AIDS), 2-21, 3-9, 5-29, active treatment phase, 7-1, 7-15, 7-16 acupuncture, 7-11 acute problem, 1-1, 1-8 acute treatment stage, 7-1, 7-15 ADAMHA, see Alcohol, Drug Abuse, and Mental Health Administration adaptation, 7-15 ADD, see Attention Deficit Disorder addict, 4-11, 6-12, 8-12 addiction, iii, 5-48, 6-6, 6-10, 8-12, 8-13, 10-2 “addictive personality,” 4-1, 4-12 ADH; ADHD, see Attention Deficit-Hyperactivity Disorder adipose tissue, 5-13 admiration of others, 9-7 adolescence, 3-8, 3-18, 4-8, 4-10, 6-11, 6-12, 8-5, 9-7 adolescents, 3-3, 3-9, 3-10, 3-13, 4-14, 5-41, 7-24, 7-25 adoptees, 5-47 adoptive parents, 5-1 adrenal gland, 5-19 adult, Adult Children of Alcoholism (ACOA), 1-20 adults, 4-10, 4-11, 4-14, 5-13, 5-15, 6-15, 7-28, 8-5, 8-9, 8-10, 9-11, 9-31 advertising campaigns, 10-12 advocacy, 8-2 aerosol propellants, 5-39 affect, 4-2 affective disorders, 5-42 affinity, 5-10 African-Americans, 1-12, 2-12, 3-24, 3-30, 7-30, 9-19 after-school activities, 9-21 African Americans, 8-9 aftercare, 7-16 age, 1-9, 2-12, 3-6, 3-7, 3-12, 3-15, 3-29, 4-11, 5-13, 7-6, 7-19, 7-28, 8-4 age of 21, 7-28, 8-4 age-graded activity, 4-11 age-stages, 4-10, 4-11 aggressiveness, pattern of higher, 6-11 aging, 4-10, 9-11 agonists, 5-10, 5-13, 5-34 agonist/antagonist, mixed, 5-10 Aid to Dependent Children (A.D.C.), 9-17 AIDS, see Acquired Immuno-Deficiency Syndrome Alanon, 1-19, 4-13 Alateen, 1-19 albumin, 5-11 alcohol, consumption and fatal motor vehicle accidents, 2-29 involvement in child sexual assault and incest cases, 2-31 problems, and frequency of remission for, 7-6 smoking, and heavy drinking, correlation between, 5-40 patterns of risk for problem use of, 2-34, 6-12 alcohol dehydrogenase, 4-6 Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA), 1-16 alcohol or drug taking, antecedents of, 7-12 alcohol use, and other drug-related behaviors, causes of problematic, 7-35 connection between violent behaviors and other drug use, 2-31 alcohol-involved crashes and license status, 2-30 alcohol-involved drivers, 8-7 “alcoholic,” 4-8, 4-11, 4-15, 5-19, 5-20, 5-22, 5-34, 5-46, 5-47, 5-48, 6-2, 6-6, 6-12, 9-3 behavior, alcoholics, 4-13, 5-47, 6-15, 8-4 Alcoholics Anonymous (AA), 1-15, 1-19, 1-20, 3-13, 4-15, 6-17, 7-6, 7-11, 7-13, 7-36 “alcoholism,” 1-16, 1-19, 2-11, 3-29, 4-7, 4-12, 5-22, 5-46, 5-48, 6-3, 6-16, 6-17, 7-13 antisocial, without antisocial “co-morbidity,” 6-15 alcoholism and other drug abuse, causes of, 6-2 alcoholisms, different, 5-47, 6-15 alertness, 5-1 Allen, case of, 9-30, 9-31 allergic reactions, 7-23 “allergy” concept, 7-13 alternative patterns, development of, 3-12 amantadine, 5-30 ambiguous messages and practices, 10-12 American amino acids, 5-4 amnesia, 2-32 periodic, amotivational syndrome, 5-39 amphetamines, 1-10, 1-20, 2-31, 5-2, 5-16, 5-24, 5-30, 5-41, 5-42, 5-46, 8-12, 8-13 anabolic steroids, 5-41, 8-12 anatomy, 5-1 androgenic effects, 5-41 anecdotal evidence, 2-4, 7-19 anesthesiologists, 5-22, 5-24 anesthetic, 5-24, 5-37 angel dust, 5-37 anger, 2-26, 2-33, 4-3 angina, 5-39 animals, studies on, 5-47 anonymity, 2-12 Antabuse¨, 4-7, 5-22, 7-6, 7-11, 7-12, 7-13, 7-17 antagonists, 5-10, 5-34, 5-42 anthropologists, 9-3 anti-anxiety agents, 5-22 anti-drug messages, 7-25 anti-narcotic legislation, 1-15 anti-Semitism, 3-30 antidepressants, 5-30, 7-12 antihistamine, 5-41 antipsychotic medication, 5-17, 5-32, 5-42 antisocial, and nonantisocial alcoholics, 6-14, 6-17 anxiety, 2-32, 5-15, 5-20, 5-23, 6-9, 6-15, 7-24, 9-27 aphrodisiac, 5-46 appearance, 3-7 appetite, 5-24, 5-29 arrests, 2-3, 7-22, 7-28, 7-29 asexual, 3-19 ashram, 3-11 Asians, 4-7 Asian-Americans, 3-24, 3-30 aspirin, 4-3 assault and battery, 2-31 assaults, 2-26 assertiveness training, 7-30 assessment, 2-33, 3-14, 6-13, 6-17, 6-18, 7-1, 7-16, 7-20, 7-24, 7-32, 8-9, 9-2, 10-2, 10-6 assimilation, 3-1, 3-6, 3-23 assumptions, 3-21 Ativan¨, 5-22 Attention Deficit Disorder (ADD), 5-30 Attention Deficit-Hyperactivity Disorder (ADH, ADHD), 4-6, 5-30 attitudes, 2-26, 3-15, 4-1, 4-3, 10-7 negative, authors, i
automobile accidents, 2-26
autonomic nervous system, 5-2
autonomy, 3-25
availability, 7-7, 7-18, 8-3
award plaques, 3-5
axon, 5-2, 5-4
B
babies, cocaine-exposed, 5-29
background, 9-3
“bad trip,” 5-36
banks, 3-4
barbiturates, 2-24, 2-31, 5-16, 5-37, 9-11
barriers, 2-34, 3-7
bars, 2-32, 6-9
basal ganglia, 5-6
battered women, 2-31
battering, 8-9
beer, 1-14, 5-18, 8-4, 9-8, 9-9, 9-12, 9-31
behavior, 4-1, 4-2, 4-3, 4-9, 7-29
Being African-American, pride in, 3-30 belief systems, 3-3 and limitations, evaluate potential, 2-4 bicultural, 3-24, 3-25 Big Book, 7-36 bilingual staff, 3-32 Bill, case of, 4-4, 9-19, 9-20, 9-23 billboard marketing, 6-9 binding sites, competing for, 5-16 binge eating, 9-32 biochemical, causes for substance abuse problems, 5-1 component of alcohol and drug problems, 4-12, 5-1, 5-46 differences between women and men, 3-19, 4-6 biomedical factors, 5-13 biophysical treatments, 7-1, 7-11 biphasic, 5-33 bipolar manic-depressive, 5-42 birth, 4-10 defects, bisexual, 3-19 bleach, 5-45 blood, circulation, blood-alcohol level, 5-12, 5-13, 5-19, 8-11 boredom, 7-32 boss, 9-4 bourbon, 9-20 boyfriends, 3-13 boys, 3-12, 3-13, 3-20, 4-4 brain, 5-1, 5-2, 5-6, 5-10, 5-11, 5-12, 5-14, 5-16, 5-17, 5-18, 5-19, 5-22, 5-23, 5-25, 5-38, 5-39, 5-45, 5-46, 5-48 brain stem, 5-8 breast development, 5-41 Breathalyzerª, 5-12, 5-19
breathing, 5-2, 5-6, 5-13, 5-33, 5-34
Brenda, case of, 9-29
British, 1-13
broken limb, 7-15
bromocryptine, 5-30
Buchman, Dr. Frank, 1-19
buprenorphine, 5-10
burying drug supplies and equipment, 3-4
C
caffeine, 1-9, 2-2, 5-8, 5-24, 5-40, 5-41
caloric value, 5-19 Cambodians, 9-15 car accidents, efforts to prevent alcohol and other drug-related, 7-23 cancer, 2-18, 2-21, 7-6, 9-13 Cannabis sativa, see marijuana car crashes, 7-23, 7-24 cardiovascular, stress, care-taking responsibilities, 7-31 career changes, 9-10 caretaker child, 9-12 caring for aged parents, 9-10 case management, 7-2, 7-21, 8-3, 8-11 case-finding, 1-8, 7-22 caste system, 3-26 Catapres¨, 5-34 catatonia, 5-37 Caucasion, 2-12, 3-2, 8-9 causal models, 6-16 “causes,” 6-12, 7-4 celebrations, 2-4 cell body, 5-2 Center for Mental Health Services (CMHS), 1-16 Center for Substance Abuse Prevention (CSAP), 1-16 Center for Substance Abuse Services (CSAS), iii, 1-18, 2-13, 7-21, 8-2 Center for Substance Abuse Treatment (CSAT), 1-16 Central America, 3-24 central nervous system (CNS), 5-1, 5-2, 5-17, 5-23, 5-27, 5-36 cerebellar cortex, 5-8 cerebellum, 5-8 cerebral cortex, 5-1, 5-6 ceremonies, 3-5 certification, counselor, 7-18 Charles, case of, 3-9, 9-8, 9-9, 9-12, 9-15 chemical dependency, iii, 5-41, 6-6 settings, chemotherapy, 5-38 chewing gum, 5-24 child, 2-33, 4-9, 4-10, 4-13, 7-22, 7-25, 9-12 childhood, 4-9, 4-10, 9-18 children, 2-32, 2-33, 3-8, 3-15, 3-16, 3-19, 3-23, 4-8, 4-13, 4-14, 5-1, 5-14, 6-15, 7-17, 7-24, 7-30, 8-12, 9-12 China, 5-38 Chinese immigrants, 1-12 chlorpromazine, 5-36 chocolate, 5-40 Christian Bibles, 1-11 chronic, problem, “chug-a-lug” contests, 2-21, 5-13 church, 3-9, 3-11, 7-26, 9-22 cigarette smoking, 2-3, 4-5, 5-40, 8-14, 9-32 cirrhosis, 2-18, 6-10 citizenship, good, 10-12 Civil War, 5-30, 5-32 class, 3-1, 3-26, 9-13 differences, classical conditioning, 4-1, 4-7, 4-8 classrooms, 2-31 client; clients, 3-32, 9-4 clinical experience, 10-4 clonidine, 5-34 clorpromazine, 5-6 club, 3-11, 3-12 CMHS, see Center for Mental Health Services CNS, see central nervous system co-dependence, 4-1, 4-13, 4-15 co-dependent relationships, 4-15 co-morbidity, 2-20, 6-1, 6-15, 6-17 co-occurrence, 6-16 co-occurring problems, 2-20 co-workers, 3-3 Coca Cola, 1-11 coca leaves, 1-12, 5-24 cocaine, 1-10, 1-12, 2-20, 2-22, 2-23, 2-24, 2-26, 3-27, 4-3, 5-2, 5-6, 5-10, 5-12, 5-14, 5-16, 5-24, 5-25, 5-26, 5-27, 5-29, 5-30, 5-32, 5-42, 5-46, 6-3, 8-4, 8-12, 8-13, 9-17, 9-18, 9-32 “bugs,” “crack,” 2-3, 2-24, 2-31, 3-27, 5-10, 5-13, 5-24, 5-27, 5-46, 8-4, 9-17, 10-2 codeine, 5-32, 5-33, 5-34 coffee, 1-9, 2-2, 4-3, 4-10, 5-40 cognition, 3-8, 4-1, 4-8 “cognitions,” 4-3 cognitive, processes, college students, 2-17, 2-24, 4-11, 7-17 colonial period, 1-13 coma, 5-13, 5-19, 5-33 communication, 9-6, 10-7 communities, 2-31, 3-3, 7-17, 10-13 community, 7-21, 7-22, 7-26, 7-32, 7-35, 8-2, 9-5, 9-23 attitudes, competence, instrumental, 3-25 composition, 5-13 Comprehensive Drug Abuse Prevention and Control Act of 1970, 5-43 compulsion, 5-14 compulsive scratching, 5-29 computer, 10-5 conceptual models, 6-3, 7-12 confidentiality, 8-10, 8-11, 9-6 conflict, 3-17 conflicting messages, 7-29 “confluent” education movements, 7-2, 7-25 “conformity,” 3-12 confrontation, constructive, 8-10 confusion, 5-20, 5-24, 9-11 congenital, 5-1 connectedness, 3-26 connection between violent behaviors and alcohol and other drug use, 2-31 consent, client’s written, 8-10 consequences, 1-9, 3-1, 3-9, 3-29, 5-1, 7-31, 10-10 constitutional factors, 4-9 constraints, 1-11 “constructive suspicion and resistance,” 3-31, 3-32 consultation, 8-11 consumer action groups, 1-20 consumption, reduction of overall, within a population, 7-26, 7-28 contests, 7-29 continents, 3-3 continuation, 6-7 contracts, between students and parents, 7-28 control policy and availability, 8-2 controlled substances, 5-43 controlled trials, 7-19 controls, 1-11, 1-12 convulsions, 5-14 coping skills, 2-33, 3-8, 3-10, 7-31 cord blood at delivery, 8-12 cortex, 5-27 cost, containment, counseling, 7-14, 7-18, 9-21, 7-15 counselors, 3-13, 3-31, 3-32, 9-2, 9-4, 9-6, 9-9, 9-12 countries, 3-3, 3-10 course, 6-1, 6-6 courts, 3-4, 7-21 “crack,” babies, cocaine, 2-3, 2-24, 2-31, 3-27, 5-10, 5-13, 5-24, 5-27, 5-46, 8-4, 9-17, 10-2 crank, 5-14, 5-30 crash, 5-29 craving, 4-12, 5-14, 5-20, 5-29, 5-30 creativity, 3-8 crime, 2-27, 7-24 criminal behavior, drug-related, 7-12 criminal justice system, 2-31, 8-8 crisis, 2-20, 3-9 centers, cross-dependence, 5-23 cross-over effects, 5-23 cross-tolerance, 5-36 crystal, 5-30 CSAP, see Center for Substance Abuse Prevention CSAS, see Center for Substance Abuse Servies CSAT, see Center for Substance Abuse Treatment Cuba, 3-24 culture; cultural, 3-1, 3-4, 3-21, 9-13 regulation/norm-focused approaches, 7-29 cure, 7-5, 7-6
curiosity, 6-12, 7-25
custody, chain of, 8-11
customs, 3-3
“cutoff” levels, 5-16
cycles in problem use, 1-12

D

D-Lysergic acid diethylamide (LSD), 5-35
data, difficulty of collecting and combining clear and reliable, 8-7
database, 10-1, 10-5
DAWN, 2-24, 2-25
dealers, 1-12, 8-4
“dealing” drugs, 2-33, 3-9, 8-13
death, 4-10, 7-36
DecaDurabolin¨, 5-41 decision-making and behavior, studies of health-related, 7-25 decisions, making your own, 3-13 decongestant, 5-24, 5-41 decreased sperm production, 5-41 decriminalization, 5-38, 8-1, 8-13 Dederich, Chuck, 1-20 definitions, 3-2 dehydration, 5-20 Delia, case of, 3-9, 9-7, 9-9, 9-12, 9-15 delirium tremens, 5-20 delta-9-tetrahydrocannabinol, 5-37 dementia, 5-14 Demerol¨, 5-32, 5-33, 5-34 demographic information, 10-1, 10-5 dendrites, 5-2, 5-4 denial, 8-12 dependence; dependency, 5-1, 5-3, 5-14, 5-15, 5-17, 5-20, 5-22, 5-30, 5-32, 5-33, 5-34, 5-39, 5-40, 5-41, 5-42, 5-43, 5-45, 5-46, 5-47, 5-48, 6-3, 8-13, 10-2 depersonalization, 5-36 depressants, 2-31, 5-17, 5-30, 5-34 depression, 2-20, 2-26, 2-33, 3-8, 5-13, 5-16, 5-19, 5-23, 5-29, 5-30, 5-32, 5-33, 5-37, 6-9, 6-15, 6-16, 6-17, 7-12, 9-13, 9-14, 9-18 designer drugs, 2-3 desired outcomes, 7-3 desmethylimipramine, 5-30 destructive behaviors, 3-11 detoxification, 5-23, 5-33, 5-34, 7-16 development, 4-1, 4-15 deviance, 3-6, 3-28 deviant, 10-11 careers, Dexadrine¨, 5-30 dextroamphetamine, 5-30 diabetic, 5-35 diacetyl morphine, 1-11, 1-14 diagnosing disorders of adulthood in patients who are not yet adults, 8-5 diagnosis, 2-20, 8-6 diagnostic criteria for various psychiatric disorders, 2-11 Diannabol¨, 5-41 diazepam, 9-13 diet pills, 4-2 diet-aid, 5-24 Dilaudid¨, 5-32, 5-33 dimensions, 3-3, 3-15 dimethoxyamphetamine (DMA), 5-36 dimethoxymethyl-amphetamine (DOM), 5-36 disabilities, 3-6, 3-29, 7-30 disabled, 3-7, 3-8 disapproval of others, 2-3 discrimination, 1-12, 3-3, 3-7, 3-23, 3-28, 3-29, 7-30, 8-2 disorder, chronic, 1-1, 1-8 disorientation, 5-20, 5-23 disruption, 3-20 dissociative states, 2-32 distilled spirits, 1-13 distribution, 2-1, 2-5, 5-11 distributors, 1-12 disulfiram, 7-11, 7-12 diuresis, 5-20 diversity, 3-2 Division of Adult Health, 1-17 divorce, 2-33, 3-8, 4-12 DMA, see dimethoxyamphetamine dollars spent on health care, 2-31 Dolophine¨, 5-33, 5-34, 5-35, 7-11, 7-12 DOM, see dimethoxymethyl-amphetamine “dominant culture,” 3-23 dopamine, 5-6, 5-20, 5-29, 5-30, 5-32 dope fiend, 1-7 dosages, difficulties with, 9-11 dose, 2-5, 5-12 dose/effect relationship, 5-8, 5-9, 5-10 dosing schedule, 5-12 double standards about inebriated behavior in women, 8-9 “downer,” 4-10, 5-41 drink, learning how to, 8-5 drink and learning, 7-28 drinkers; drinking, drinking or drug taking, comments by family or friends about, 2-33 driving, records, monitoring of questionable, 8-8 drop-in centers, storefront, 1-20 drug, 1-1, 1-8 abuse, categories of psychotropic substances, 5-43 crops and importing activities, reduction of, 7-29 Drug Abuse Warning Network, 2-24 “drug-free” existence, 5-42 drug-free therapeutic community, 7-11 drug-induced vulnerability, 2-31 drug-related, drug-taking behavior, 2-26 drugless society, 2-4 drugs, illegal; illicit, 2-2, 2-3, 3-2, 3-14, 3-20, 4-14 over-the-counter, 2-2, 2-3, 5-2, 5-24, 5-40, 9-11 drunkenness, 1-13, 3-20, 6-12
drys, 1-13
duplication of effort and of resources, 7-20
E
EAPs, see Employee Assistance Programs
Earl, case of, 3-15, 9-9, 9-11, 9-15
eating disorders, 7-30
ECA study, 2-11
economic,
benefits,
Editorial Review Board, iii education, 3-6, 3-7, 3-13, 4-2, 6-17, 7-30, 8-12, 10-7 educational, achievement, Effects of Ardent Spirits upon the Human Body and Mind, An Inquiry into (the), 1-13 efficacy, 5-10, 5-13, 7-18, 7-19 Elavil¨, 5-42 elderly, 2-3, 4-13, 5-13, 7-31 electric stimulation, 7-11 elixirs, 5-33 Elizabeth, case of, 1-10 Elkins, 3-8 emergency, empathic and caring attitude, 7-14 emphysema, 8-14 empirical, Employee Assistance Programs (EAPs), 8-1, 8-11, 9-31 employers, 2-27, 2-33 employment, changing, 4-11 enable, 2-34 endorphins, 5-32, 5-34, 5-35 Engler Administration, 1-18 ENT specialists, 5-24 environment, 3-3, 3-12, 3-14, 3-16, 3-22, 4-9, 4-10, 4-14, 5-46, 6-3, 6-11 enzymes, 4-7, 5-23, 5-25 Epidemiologic Catchment Area study, 2-11 epidemiologic model, 6-3, 6-5 epidemiological studies, 2-11, 2-12, 3-2 epidemiology, 2-1, 2-5 epinephrine, 5-6, 5-19 episodes of terror, 2-32 ERB, see Editorial Review Board Erythroxylon coca, 5-24 escape, 3-18 Eskimo, 4-8 estrogen, 5-41 ethanol, 5-17, 5-18, 5-19, 5-20 ethical issues, 7-21, 8-10, 9-6 ethnical problems, 9-6 ethnicity, 1-9, 2-12, 3-1, 3-6, 3-22, 3-29, 7-30, 7-31, 9-15 ethyl alcohol, 5-18 etiologic models, 6-3, 7-12 etiology, 6-1, 6-2, 6-17 euphoric effect, 5-29 Europe, 5-24, 5-38 Europeans, 3-24 evaluation, Everycity High School, 9-19 exchange of sex for drugs, 9-18 excitement, 5-27 excretion, 5-10, 5-11, 5-12 exhaled air, 5-12, 5-15, 5-19 expectancy, 4-1, 4-8 expectations, 2-31, 3-6, 3-17, 3-18, 3-19, 3-22, 4-11, 10-11 experimentation with alcohol, 9-22
experimenting, 3-9
experiments on abnormal human behavior, 5-35
exploration, 9-25
eye contact, direct, 3-26
F
facial expression, 4-3
factors,
that influence the effects of drugs, 5-1 that predispose people to use alcohol and other drugs, 7-12 to recognize or accept responsibility, 4-13 false-negative test results, 5-16 families; family, 2-27, 2-31, 3-1, 3-3, 3-4, 3-6, 3-8, 3-9, 3-9, 3-10, 3-13, 3-15, 3-18, 4-3, 6-17, 6-18, 7-4, 7-6, 7-17, 7-23, 7-25, 7-35, 8-4, 8-9, 8-10, 8-12, 9-15, 9-19, 10-13 Families First, 8-12 farms, 3-4 FAS, 5-22 fat level, 5-19 fate, 6-12 father, 3-15, 3-16, 9-16 fathers of alcoholics, 5-47 fatigue, 5-30, 5-39, 5-40, 5-42 fear, 2-32 feces, 5-12, 5-15 federal, agencies, federalized state militias, 1-14 feedback, 7-2, 7-20 feeling; feelings, connected, Fetal Alcohol Syndrome, 5-22 fetus, 5-13 fighting, 2-31 “filthy habit,” 3-11 finances, 2-34 financial, findings, application of, 8-11 fines, 7-29 fingernail samples, 5-15 first communication gap, 1-2 first use, prohibit, 3-11 first-level, or primary prevention, 7-1, 7-5 “first-order” process, 5-12 “fitting in,” 9-9, 9-31 flashbacks, 2-32, 5-36 flu, 5-34 food and drug legislation, 1-15 foreign beers, 5-18 formal controls on the sale of alcoholic beverages, 8-4 “formal operational thinking,” 3-8 fortified wines, 5-18 Fortune 500, 8-11 frank paranoid psychosis, 5-29 fraternity, 7-29 freebase, 5-10, 5-27 freedom, individual, 10-13 Freud, Sigmund, 5-24 friends, 3-3, 3-9, 8-4, 8-12, 9-10, 9-12 fun, acceptable ways of having, 3-9 functional, impairment, Fundamentals of Substance Abuse Counseling, iii
funding, 7-18, 8-2, 10-6
fungal infections, 5-45
G
gamma aminobutyric acid (GABA), 5-6
gangs, 2-31, 3-12
gas chromatography with mass spectrometry (GCMS), 5-16
gasoline, 5-39
gastric enzymes, 5-13
gastrointestinal,
pathology,
GCMS, see Gas Chromatography with Mass Spectrometry gender, 1-9, 2-12, 2-31, 3-1, 3-6, 3-12, 3-18, 3-19, 3-29, 4-2, 5-13, 7-30, 8-9, 9-4, 9-13, 9-26 generic treatments, 7-17 genes; genetics; genotype, 4-14, 6-1, 7-4, 7-13 effects linked to some forms of alcoholism, 6-16 geographic region, 1-9 George, case of, 9-31 German, 1-12 soldiers, gin, 1-13 girls, 3-3, 3-13, 3-20, 4-4 glaucoma, 5-38 glue, 5-8, sniffing, glutamate, 5-6 goals, 4-14, 7-1, 7-3, 7-4, 7-7, 7-11, 7-12, 7-28 God, good creature of, 1-13 “gold standard,” gonorrhea, 5-46 government, 3-4, 10-12 graduation ceremonies, 3-4 grand mal, 5-20 grandchildren, 9-9 grants and contracts, 8-2 Great Britain, 1-13, 8-14 Great Society, 1-20 Gregory, case of, 1-10 group, acceptance, H
“habilitation,” 3-10, 7-28
hair, 5-18
Haldol¨, 5-42 half-life, 5-12, 5-13, 5-23 hallucinations, 5-20, 5-24 tactile, happiness, 4-3 Harrison Narcotics Act, 1-12, 1-14, 5-24, 5-32 hash oil, 5-37 hashish, 1-11, 5-37, 9-27 head rush, 5-39 headaches, migraine, healing process, 7-36 health, 3-26, 7-5, 7-28, 10-12 and social consequences of alcohol use, 8-13 health insurance, universal, 10-9 Health Maintenance Organization (HMO), 8-3 health problems, drug-related, major, 2-20, 7-22 health services research, 10-2 heart, 5-29 attack, heavy use, 3-11 Helen, case of, 5-29, 9-16, 9-18 help, need to seek, 2-33, 3-26 help giving, vital ingredients of, 7-14 hemp plant, 1-11, 5-40 hepatitis, 5-32, 7-12 heroin, 1-11, 1-14, 1-15, 2-3, 2-24, 5-10, 5-13, 5-25, 5-29, 5-30, 5-32, 5-33, 5-34, 5-45, 6-7, 6-13, 7-12, 8-4, 8-13, 8-14, 9-27 heterosexual, 3-19, 9-26 “hidden events,” 4-2 “high,” 5-29 high risk, 3-25, 9-7 drivers, high school, 2-5, 2-6, 2-16, 8-12 “high-class” drug, 3-27 highway safety and alcohol, 8-6 Hindus, 1-11 hippocampus, 5-6, 5-27 histamine, 5-33 historical and cultural shifts, 10-2 historical issues, 1-10 HIV, see Human Immuno-Deficiency Virus HMO, see Health Maintenance Organization hobby, 4-14 holiday parties, 2-32 holidays, 3-5 homicidal, 5-29 homicides, 2-21, 2-23 homophobic attacks, 3-30 homosexual, 3-19 men, hospitals, 2-20, 2-24 host factors, 6-3 housing, 3-4 human context of intervention, 7-35 Human Immuno-Deficiency Virus (HIV), 5-32, 5-35, 5-45, 5-46, 8-15, 9-18 hydromorphone, 5-32 hyperactive, 5-30, 6-11 hyperbaric oxygen, 7-11 hypertension, 9-11 hyperthermia, 5-20 hypnotics, 5-17, 5-22 hypodermic syringe, 1-14, 5-32
hypothalamus, 5-6, 5-27

I

ice, 5-14, 5-30
identification, 6-18, 7-2, 7-21, 7-30
early,
ideology, 10-3 ill, becoming, 3-8 illegal drugs; illicit drugs, 2-2, 2-3, 3-2, 3-14, 3-20, 4-14 illness, 3-8 imitation learning, 4-8 immigrants, 3-23 importers, 1-12 improvement, impulsivity, 6-9 incarceration, 3-3, 8-4 incentives not to use drugs, 3-12, 9-22 incest, 2-33, 9-19 incidence, 2-1, 2-5 income, 3-6, 3-26 increased expense of using drugs, 7-28 India, 3-26 Indians in Peru, 5-24 indicators, 2-26, 2-33, 3-11 indigenous healers, 3-24 individual, immunizations for, list of routine, 5-45 infections, bacterial, 5-45 infectious complications of drug use, 5-45 influence, 3-7, 9-5 and knowledge, distinction between, 10-3 inhalants, 5-8, 5-39, 9-32 inhalation, 5-10 inhibitions, 2-31 initial treatment, 1-8 injury, 2-32, 3-7 “inoculation” approaches, 7-26 inpatient, 7-17 facilities, insanity, temporary, 5-35 insight, 3-25 insomnia, 5-20, 5-22, 5-23 instability, 4-11 institutions, 3-3, 5-42 instrumental competence, 3-25 insufflation, 5-25 insulin, 5-35 insurance, 3-28, 3-29, 8-3 integrated health care systems, 10-9 integrative models, 7-1, 7-13 interact, 9-1, 9-25 interaction, 2-20, 9-3 among drugs taken for physical problems, 7-30 interest group, 3-11 “internalized discrimination,” 3-31, 3-32 international agreements, 7-4 interpersonal, skills, interplay between biological and psychological functioning, 4-8 interpretations of results, determining legitimate, 2-4 intervention; interventions, 1-1, 1-7, 1-10, 1-18, 2-4, 2-20, 2-32, 2-33, 3-2, 3-3, 3-9, 3-18, 4-11, 6-2, 6-12, 6-15, 6-16, 6-17, 6-18, 7-5, 7-14, 7-29, 7-30, 7-32, 8-9, 8-11, 8-12, 9-3, 10-2 intoxication, 5-15, 6-11, 7-16, 8-13 intranasal, snorting, intravenous (I.V.) drug users (IVDUs), 5-45, 5-46, 8-14, 8-15 intravenous injection, 5-25 “invasion” by a foreign substance, 5-14 involuntary functions, 5-2 Irish, 1-12 irritability, 5-20, 8-10 isolation, 7-32 issues relevant to aging, 9-9 IVDUs, see intravenous drug users
J
jail, 3-10, 7-29, 8-7
Jan, case of, 4-5, 4-6
jargon, ii, 10-4
gap,
Jellinek, E. M., 1-15 Jerry, case of, 9-3 Jews, 1-11, 3-24, 3-30 Orthodox, Jim, case of, 9-3, 9-4 job, 6-17, 6-18 development, John, case of, 3-20, 9-12, 9-13, 9-15
Johnson, President Lyndon, 1-20
joints, 5-37
Journal of Studies on Alcohol, Quarterly, 10-3
joy, 4-3
“Just say no,” 4-2, 8-4
K
kidneys, 5-11, 5-13, 5-14
kindling, 5-27
knowledge, 10-7, 10-13
and information, distinction between, 10-3
L
L-DOPA, 5-30
labeling, 8-6
labels, 3-18, 3-30 Laboratory of Applied Physiology, 10-3 lack of, discipline, perceived options for meaningful work, 7-30 laid off, being, 4-11 language, 3-6, 3-7, 4-8 law and practice, contradictions and inconsistencies in, 2-2, 8-5 law enforcement, 2-31 strategies, laws, 2-2, 3-11, 6-4, 7-4, 7-23, 7-29, 8-4, 9-24, 10-12 against the sale of alcohol and tobacco to minors, 7-28 and policies, variation in how they get enforced, 8-9 lay movements, 1-1, 1-18 laying on of hands, 7-36 leadership structures, 3-12 learning, 4-1, 4-2, 4-15 leaving home, 4-10, 4-14 legal, 2-2 “legal limit” of intoxication, 5-22 legalization of illicit drugs, 8-1, 8-13 legislation, 1-14, 8-2 leisure class, 3-26 length of problem, 7-19 lesbian, 9-26 lesion in the brain, 5-45 lethal, 5-19 level of, care, Librium¨, 5-25, 5-26 license status at crashes with alcohol involvement, 2-27 licensed programs, 8-10 life, circumstances, lifestyle, 3-26, 3-22, 3-27, 4-9, 5-17, 9-13, 3-6, 10-12 lighter fluid, 5-42 limbic system, 5-1, 5-10, 5-32 alcohol consumption and violent and nonviolent crimes, 2-28 violent and nonviolent crimes and fatal motor accidents, 2-27 “lipid loving,” 5-13 lipophilic, 5-2, 5-13 liquor, 5-20, 8-4 Lisa, case of, 3-20, 9-13, 9-14 literature, 3-4 lithium, 5-42 liver, 5-11, 5-12, 5-14, 5-16, 5-23, 5-29, 5-33, 5-38, 5-39, 5-41, 5-45, 8-14 enzymes, living arrangements, supportive, 7-16 “load,” 5-13 long-term effects associated with chronic use, 2-21 look-alikes, 5-41 loss, low self-esteem, 4-12, 4-14
lower-class, 3-26, 3-28
LSD, 5-35, 5-36
lung cancer, 6-10, 8-14
Lysergic acid diethylamide, see LSD
M
MADD, see Mothers Against Drunk Drivers
magic bullet, 5-22, 5-41
main culture, 3-23
maintenance, 5-33, 5-35, 7-1, 7-15, 7-16
male, 2-11, 3-18, 4-4, 6-11, 8-9
characteristics,
malt liquors, 5-18 managed care, 8-1, 8-3 mania, 5-24, 5-42, 6-15 manic-depressive, 5-42 manufacturers, 1-12 Marihuana Tax Act of 1937, 1-15, 5-38 marijuana, 1-9, 1-10, 1-11, 1-20, 2-3, 2-7, 2-21, 4-3, 5-11, 5-13, 5-25, 5-35, 5-37, 8-13, 9-8, 9-12, 9-17, 9-18, 9-27, 9-32 married, getting, 4-10 Marshall, Dr. O., 1-14 Martha Washington Societies, 1-19 Mary, case of, 3-15, 9-10, 9-11, 9-12, 9-15, 9-31 masculinity, 3-20 master file of Michigan, 8-8 Mather, Cotton, maturation, 4-10 Mazaraki, A. Gail, iv meaning, 3-17 means of manufacture, 7-23 meconium drug levels, 5-15 media, campaigns, role in disseminating knowledge as well as myth, 10-2 Medicaid, 10-8, 8-14 medical, emergency, Medicare, 10-8 medication, 5-22, 5-29 reactions, Mellaril¨, 5-42 “melting pot,” 3-23 membership, 3-12 men, 2-33, 3-2, 3-3, 3-12, 3-20, 3-26, 4-2, 5-13, 5-19, 6-17, 7-31, 8-12, 9-4, 9-10, 9-14 mescaline, 5-35, 5-36 metabolic rate, 5-11 metabolism, 4-6, 5-10, 5-11, 5-12, 5-14, 5-16, 5-18, 5-19, 5-23, 7-13 metabolites, 5-11, 5-23, 5-25 methadone, 1-15, 5-29, 5-32, 5-33, 5-34, 7-11, 7-12, 7-16, 7-17 methamphetamine, 5-14, 5-30 methylphenidate, 5-24 Mexican mushroom, 5-36 Mexican-Indian religious rituals, 5-36 Mexico, 3-24 Michigan, 1-16, 5-30, 5-43, 5-45, 7-7, 7-21, 8-2, 8-4, 8-8, 8-14 Michigan Department of Public Health (MDPH), 1-17 midbrain, 5-8, 5-27 middle age, 4-10, 5-13, 9-13 men, middle-class, 3-26 migraine headaches, 5-22 mimic of psychosis, 5-35 Minnesota, 7-21 minors, 7-28 mixed drinks, 9-8, 9-9, 9-30 modality, 7-1, 7-7, 7-11, 7-13 model, disease, 6-3 models, 3-2, 3-20, 6-1, 6-2, 6-3, 6-6, 6-13, 6-16, 6-17, 7-3, 7-12 current, modeling, 4-1, 4-7, 4-8 money, 7-24, 7-28 management, monitoring services, 9-6 mood, 2-33, 5-1 morbidity, 2-1, 2-18 morphine, 1-11, 1-14, 5-30, 5-32, 5-33 dependence, mortality, 2-1, 2-18, 2-20 Mothers Against Drunk Drivers (MADD), 1-20 motivational factors, 4-9 motor tremor, 5-15, 5-20 Mrs. Winslow’s Soothing Syrup, 1-11, 1-14 multi-cultural, 3-23 multicausal (multifactorial) models, 6-6 elements of identities and influences on behavior, 3-6 murder, 2-26, 2-31
muscle building, 5-41
N
NA, see Narcotics Anonymous
nails, 5-15
naloxone, 5-34
naltrexone, 5-34
Narcan¨, 5-34 narcolepsy, 5-30 “narcotic,” 5-10, 5-17, 5-32, 6-9, 7-12, 9-27 narcotic antagonists, 7-12 Narcotics Anonymous (NA), 7-11 nasal septum, perforation of the, 5-29 national, National Clearinghouse on Alcohol and Drug Information (NCADI), 1-16 National Council on Alcoholism (NCA), 1-15 National Institute on Alcohol Abuse and Alcoholism (NIAAA), 1-16 National Institute on Drug Abuse (NIDA), 1-16, 6-17 National Institute on Mental Health (NIMH), 1-16 National Institutes of Health (NIH), 1-16 Native American, 3-24, 3-30, 4-7, 5-22, 5-36, 9-15, 9-19 nature versus nurture, 5-47 nausea, 5-20 NCA, see National Council on Alcoholism NCADI, see National Clearinghouse on Alcohol and Drug Information needle sharing, 5-45, 5-46 needle-disinfecting techniques, 8-14 needle-exchange programs, 8-14 needles, 5-32, 5-35, 5-45 needs, personal, 4-11, negative, consequences, reduction of the potential of, from early use, 7-28 neglect, 2-27, 4-13, 9-18 neighborhoods, 3-3, 3-10, 3-11, 7-4, 7-35, 10-13 neighbors, 8-4 Nembutal¨, 5-22, 5-23 nerve function, 5-1 nervous system, 5-1 neurochemical, neurons, 5-2, 5-3, 5-4, 5-5, 5-20, 5-29, 5-34 neurotransmitters, 5-4, 5-6, 5-20, 5-29, 5-30, 5-32 newborn, 5-15 NIAAA, see National Institute on Alcohol Abuse and Alcoholism nicotine, 1-9, 2-2, 5-40 NIDA, see National Institute on Drug Abuse nightcap, 9-30 NIH, see National Institutes of Health NIMH, see National Institute on Mental Health nitrites, 5-39 nitrous oxide, 5-39 No-Doz¨, 5-40 no-treatment condition, 7-19 nod, 5-33 non-alcohol-related diagnoses, 2-19 non-antisocial persons with drug involvement, 6-18 norepinephrine, 5-6, 5-20, 5-29, 5-32 “normal” people, 3-28, 4-12 normalcy, maintaining, 2-4 norms, 3-1, 3-6, 3-10, 3-14, 3-30, 7-29, 9-9, 10-11, 10-12, 10-13 Norpramin¨, 5-30, 5-42
“noxious or infectious agent” factors, 6-3
numbness, 2-32
nystagmus, 5-19
O
obese, 5-13
obsessive-compulsive disorders, 5-42
occupations, 3-6, 3-26, 4-2
offenders, repeat, 8-7
Office of Drug Abuse (ODA), 1-17
Office of Drug Abuse and Alcoholism (ODAA), iii, 1-17
Office of Substance Abuse Prevention (OSAP), 1-16
Office of Substance Abuse Services (OSAS), iii, 1-17
Office of Treatment Improvement (OTI), 1-16
older people, 3-3
(first use) of drug use, delaying, 6-11, 7-28 opiates; opioid, 1-12, 1-13, 1-14, 2-31, 5-8, 5-10, 5-17, 5-32, 5-33, 5-35, 5-37, 5-43, 6-9, 7-7, 7-11, 7-12, 7-16, 7-17 antagonists, “opium eaters,” 1-14 “Opium Habit in Michigan,” (The), 1-14 optimistic personality, 4-14 oral disclosure, 8-10 ordinances, 9-24 organ transplants, ethics of, 8-14 organizational characteristics of different treatments, 7-7, 7-18 OSAP, see Office of Substance Abuse Prevention OSAS, see Office of Substance Abuse Services OTI, see Office of Treatment Improvement otolaryngologists, 5-24 Ottawa Indian, 9-31 out-of-body experience, 5-36 outcome, 10-6 outpatient, 7-17, 9-32
outreach, or case-finding, 7-2, 7-22
over 60, 7-30
over-the-counter remedies, 2-2, 2-3, 5-2, 5-24, 9-11
overdose, 2-1, 2-20, 2-24, 3-9, 5-13, 5-19, 5-23, 5-33, 5-34, 5-36, 7-22, 7-23, 7-24
Oxford Group, 1-19
P
package stores, 6-9
pain, 5-33
paint thinners, 5-8 pairing, 4-8 paranoia, 5-24, 5-37, 5-41 paraphernalia, 3-4, 5-40 parasympathetic, 5-2 paregoric, 5-33 parent or sibling with alcohol problems, 6-7 parental substance use, 9-19 parenting, 3-9, 3-18, 8-12 parents, 3-8, 3-13, 3-16, 4-2, 4-8, 4-11, 4-14, 5-1, 7-26, 9-12 Parlodel¨, 5-30 partial agonists, 5-10 Partnership for a Drug-Free America, The, 7-26 passage of drugs through body, 5-10 passive smoking, 2-3 past experiences, 9-25 patent medicine, 5-24 pathologies; pathology, 6-10 Patrick, case of, 1-10 patterns, 2-3, 2-34, 3-9, 3-14, 3-15, 3-16, 3-29, 4-2, 4-3, 4-4, 4-5, 4-11, 4-12, 4-13, 6-12, 7-29, 8-9, 9-15, 10-2, 10-10, 10-13 PCP, 2-31, 5-35, 5-37, 5-38, 5-42 peer; peers, 4-3, 4-8, 4-9, 4-10, 4-11, 6-11, 6-15, 9-22, 9-23, 9-31 and reference groups, collecting information about, 3-14 group, 3-1, 3-3, 3-6, 3-9, 3-11, 3-14, 6-10, 7-29, 7-35, 9-9 Pentothal¨, 5-22 “people” problems, 2-3 perceived benefits, 2-27 perceptions, 5-1, 5-17, 5-19, 5-24, 5-36, 5-37, 5-38, 5-39, 9-1, 9-25 peripheral nervous system, 5-2 perpetuation of drug use, 6-7, 6-10 personal, desires to achieve and be recognized, 10-11 “personal fable,” 3-8 personality, 3-8, 4-1, 4-9, 4-10 factors, peyote cactus, 5-36 phantastics, 5-35 pharmacist, consultation with a clinical, 7-30 pharmacologic effects, 5-17, 5-19 pharmacological, action, pharmacology, 5-1 phencyclidine, 5-35, 5-37 phenobarbital, 5-22, 5-23 phenotype, 6-1, 6-16 phenylpropanolamine, 5-24 Philadelphia VA Medical Center, 6-17 philosophy, 7-1, 7-7, 7-12, 7-13 phobias, 5-42 phone lines, 1-20 physical, physicians, 7-24 physiological, dependence, Piaget, 3-8 pinpoint pupils, 5-33 pituitary gland, suppression of, 5-41 placebo effect, 4-1, 4-8, 7-19 placenta, early separation of the, 5-29 placental transfer of PCP, 5-37 plateau, 5-13 “pleasure center,” 5-6, 5-29 pneumonia, 2-18 police, 7-24, 7-30, 8-9 policy, 8-2, 10-3, 10-8, 10-13 politics, 8-2 pons, 5-8 “pony,” 4-8 poppers, 5-39 populations, 7-17 “porno” shops, 5-40 positive experiences and alcohol, 3-16 “Post-Traumatic Stress Disorder” (PTSD), 2-32, 5-42, 9-14, 9-18 postsynaptic neurons, 5-29 pot, 5-38 potential users, 7-28 poverty, 3-15, 7-30 power, 3-7, 3-26, 9-4, 9-5, 9-7 precipitating; precipitation, 6-7, 6-10 factors, preemployment exams, 8-11 pregnancy, 3-8, 3-20, 5-29, 9-18 pregnant, chemically dependent women, 5-35, 8-12 prejudice, 1-12, 3-6, 3-7, 3-29 prenatal care, 8-12 prescribe; prescribing, prescription drugs, 1-10, 1-20, 2-2, 2-3 pressures and temptations, ways of handling high-risk, 7-26 presynaptic nerve endings, 5-29 pretreatment assessment, 7-20, 7-21 prevalence, 2-1, 2-5, 2-11 prevention, 1-1, 1-15, 2-32, 3-1, 3-2, 3-5, 3-7, 3-12, 3-13, 3-14, 3-16, 3-18, 3-20, 3-21, 3-23, 3-24, 3-31, 4-6, 4-11, 6-2, 6-6, 6-12, 6-17, 6-18, 7-4, 7-26, 7-37, 8-5, 8-9, 9-3, 9-6, 9-11, 9-19, 9-24, 10-10 and treatment, natural relationship between, 7-3 primary, or first-level, 7-1, 7-5, 7-24, 7-31 second-level prevention, 7-1, 7-5, 7-22, 7-23 strategies based on a cultural orientation, 7-29 pride in being black, 3-30 prisons, 6-13 privacy, 8-11 private, organizations, problem drinker, 1-19, 6-2, 9-11 “problem use” model, 6-3 problem-solving skills, 3-16 problematic drug use, 1-9, 2-26, 2-31 problems, processes, 3-2, 3-7 producers, 1-12 productivity, diminishing, profile of eligible services, 8-2 prognosis, 6-1, 6-6 program designers, 9-6 programmed learning packages, 10-6 programs to help people quit, 2-3 progressive sensitization, 5-27 Prohibition, 1-1, 1-12, 1-13, 1-14, 1-15, 8-13, 10-3 Prolixin¨, 5-42 promiscuous, 3-20 “proof,” 5-18 prosecution, 2-3 prostitution, 9-17, 9-18 protection, 3-12 provider; providers, 7-1, 7-18 Prozac¨, 5-42 Psilocybe mushroom, 5-36 psilocybin, 5-35, 5-36 psychedelics, 5-35 psychiatric disorders, 7-30 drugs, 5-4, 5-6, 5-10, 5-11, 5-13, 5-14, 5-16, 5-17, 5-46 psychology, 4-3 psychopathology, 6-10 psychosis, 5-39, 5-42 psychosocial factors, 5-46 psychotherapeutic agents, 5-42 psychotherapy, 5-35, 7-17, 7-18, 7-35, 7-36 cognitive, psychotomimetics, 5-35 psychotropic drugs, 5-2 PTSD, see Post-Traumatic Stress Disorder (PTSD) puberty, 4-10, 4-11 public, Public Act 56, 1-17 Public Act 197, 1-17 Public Act 219, 1-16 Public Health Service Hospitals, 1-15 Puerto Rico, 3-24 pulse rate, 5-2, 5-36 punishment, 3-10, 4-6 purchase and consumption of alcohol, 8-4
Pure Food and Drug Act of 1906, 1-14
purging, 9-32
pyramid, 5-41
Q
quality of job performance, 8-11
Quarterly Journal of Studies on Alcohol, 10-3
R
race, 1-10, 3-6, 3-29, 7-19, 8-9, 9-26
radiation, 7-11
random,
assignment,
randomized controlled trial, 7-1, 7-19 rapes, 2-26, 2-31, 3-30 rapport, 7-14 rate of problems, 2-1, 2-5 ratio of services to people who need them, 8-2 rationing, 8-14 reactions, panic, 5-35, 5-36, 5-39 attacks, reasssessment, 7-20 rebellious forms of dress or behavior, 3-9 receptors, 5-6 reckless driving, 8-7 record-keeping, 10-6 recovery, 2-34, 3-12, 3-32, 6-18, 7-5, 7-36 recreational options, 7-30 reduction of, drug crops and importing activities, 7-29 referent power, 9-5 referral, 1-8, 7-2, 7-22 refugees, 3-23 refusing drugs in various circumstances, training to practice, 7-26 regional differences, 3-6 regulation, 1-1, 1-11, 1-12, 2-2, 3-11, 3-28, 7-4 rehabilitation, 1-8, 1-19, 3-1, 3-10, 7-5, 7-28 reimbursement for treatment, 2-20 reinforcement, 4-5, 4-10, 4-12 reinforcing (“addictive”) behavior, 5-8 relapse, 8-9, 8-14 driving, drinking, and traffic accidents, 8-6 social, psychological, and physiological aspects of drug use, 2-26 relationships, 3-6, 3-12, 7-22, 9-5 religions, 3-3, 3-4, 3-6, 3-9, 3-21, 3-29, 9-26 religious, institutions, “rescuer” roles, 3-16, 9-12 research, 1-6, 1-15, 1-16, 2-4, 2-32, 3-2, 4-12, 4-13, 5-1, 5-46, 5-48, 6-12, 7-3, 7-5, 7-19, 7-26, 7-28, 8-6, 8-9, 9-14, 10-2, 10-5, 10-13 residential treatment programs, 7-17, 8-12, 9-19, 9-31 resilience, 7-5, 7-31, 7-32, 7-36 resin, 5-38 resources, 3-3, 3-12, 7-4, 7-32, 7-35, 8-2, 9-23 responsibilities, 3-3 restlessness, 5-27 Restoril¨, 5-22 retirement, 4-11, 9-9, 9-10, 9-11, 9-15 “rewarding” influence, 5-17 rewards and punishments for others, control of, 3-10, 9-4 Rex, case of, 9-28 Rig-Veda, 1-11 right to purchase and freely consume alcohol, 8-4 risk, 4-13, 5-1, 5-14, 5-16, 5-29, 6-11, 6-16, 6-17, 7-31 factors, 2-5, 3-22, 6-17, 7-1, 7-4, 7-5, 7-30, 10-13 of violence, withdrawal and increased, 8-10 risk-taking behaviors, 9-9, 6-11 risky behavior, consequences of, 3-9 Ritalin¨, 5-24 rites of passage, 8-5 rituals, 2-4, 3-3, 3-4, 3-6, 3-8, 3-11, 3-21, 7-29 roadside pretesting of blood levels, 5-19 robbery, 6-11 Rogers, Carl, 7-35 role, 3-8, 3-16, 3-17, 3-18 analysis, Roman Catholic, 9-15
routes of supply, 7-23
rule structures, 4-8, 4-11, 4-15
rule-breaking behavior, 3-20
rum, 1-13, 9-13, 9-21
Rush, Benjamin, 1-13
“rush,” 5-33, 9-17
Russian Olympians, 8-12
Rutgers University, 1-15
S
SADD, see Students Against Driving Drunk
sadness, 4-3
“safe” driver, characteristics of a, 8-6
safety, 2-27, 3-32
sale of cocaine and other drugs, 5-24
Sally, case of, 4-4
Salvation Army, 1-15
SAMHSA, 1-16
sanctions on legal drugs, 2-32, 10-12
Sasha, case of, 9-26
scare tactics, 7-24
schedules, drug, 5-13, 5-43, 5-44, 7-23
schizophrenia, 2-20, 5-42, 6-10
school-based education, 9-19
schools, 3-3, 3-9, 3-10, 3-14, 4-3, 7-21, 7-30, 7-35, 8-2, 9-8, 9-9
Schrock, Karen, iii
science; scientific, 1-6, 10-11
findings, use of, in clinical practice, 10-4 scopolamine, 5-2 screening, 2-24, 7-16, 7-21, 8-8 Seconal¨, 5-16, 5-17, 5-22 second communication gap, 1-6 second-level prevention, 7-1, 7-5, 7-22, 7-23 second-hand smoke, 3-11 secondary enzymes, 5-19 sedative-hypnotics, 1-20 sedatives, 5-17, 5-22, 5-23, 5-24, 5-41, 9-27 seizure of shipments, 7-28 seizures, 5-13, 5-20, 5-22, 5-24, 5-36, 5-37 self-, medicate, 2-4, 2-32, 7-24, 7-30, 7-31, 9-10 senility, 9-11 senior citizens, 1-10, 9-9, 9-10 sensation, 5-2 sense of well being, 5-24 sentences, required, 7-29 Sernyl¨, 5-37 serotonin, 5-6, 5-8, 5-20, 5-36 service provider, 8-10 services, 1-18 setting, 7-1, 7-7, 7-17, 8-2, 8-5 severity, abuse, child, 2-31, 2-33, 9-12, 9-16, 9-17, 9-18, 9-32 orientation, 1-10, 3-6, 3-19, 3-29, 7-30 sexuality, 3-9, 9-9, 9-24 sexually transmittable disease, 5-46, 9-18 shabu, 5-30 shaking, 4-3, 5-15, 5-20, 5-23, 5-37 shame, 2-32 sharing, medications, shifts in social acceptability of use, 10-12 shock, 5-13, 5-23 short-term treatment, 1-8 shortness of breath, 5-22 SIDS, see Sudden Infant Death Syndrome significant others, 2-33, 2-34 sin, 3-29 single-cause models, 6-6, 6-17 “single-distribution hypothesis,” 8-4 sinsemilla, 5-37 site of action for drugs, 5-1 skid-row bum, 1-7 skill training, 7-32 skin, sleepiness, 5-29 small intestine, 5-18 Smith, Dr. Bob, 1-19 smokable methamphetamine, 5-30 smoke-free zones, 3-11 smoking, 3-11, 4-5, 5-25 and heavy drinking of alcohol, correlation between heavy, campaigns urging people not to start, 2-3 snappers, 5-39 snorts, 9-17 snorting, intranasal, 5-24 snuff, 5-38 sobriety on the job, 8-11 social, acceptability of heavy drinking and drug use, 6-9, 7-26 socialization, 3-1, 3-9, 3-20, 4-3, 4-8, 4-15 socially acceptable drugs, 3-20 societal, attitudes, socioeconomic class, 3-6 sociology, 3-29, 4-3 soft drinks, 1-9, 5-40 “soldier’s disease,” the, 1-14 solvents, 2-24, 5-39 soma, 5-2 sons, South America, 3-24, 5-24 Southeast Asian, 9-19 Spanish, 3-24 specialized treatment, 7-22 speech, 4-3 speed, 5-14 speedballing, 5-25 speedballs, 2-22 spinal cord, 5-1, 5-2, 5-17 spiritual, or religious experience, search for, 5-35 spirituality, 3-6, 3-9, 3-21, 7-13, 7-35, 9-32 spontaneous, sports figures as spokespersons, 3-13 spot cleaners, 5-39 spouse, 4-13, 4-15, 7-17 stability; stabilization, 4-10, 7-1, 7-4, 7-16 stack, 5-41 stage specificity, 7-1, 7-15 stages of life, 4-2 standards of beauty, 3-30 “standards” for yourself, 3-13 state and local governments, 8-4 State Board of Alcoholism, 1-16, 1-17 State Department of Public Health, 8-2 states, 3-3, 3-10 statistics, 2-26 STDs, 5-46 stereotypes, 1-7, 3-1, 3-19, 3-20, 3-29 steroids, 5-8, 5-19, 5-45, 8-13 stillbirth, 5-29 stimulants, 2-31, 4-10, 5-15, 5-17, 5-24, 5-25, 5-30, 5-34, 5-37, 5-40, 5-41, 5-43, 8-12, 8-13, 9-27 stomach, 5-15, 5-18 cramps, storefront drop-in centers, 1-20 STP, 5-36 strategy, 7-1, 7-7, 7-11 “street drugs,” 2-7 street names, 1-9 stress, 3-15, 4-14, 5-6, 7-28, 7-30, 7-31, 9-13, 9-20 stroke, 2-21, 5-14 prenatal, structure, 3-17 student protest, 7-23 Students Against Driving Drunk (SADD), 1-20, 7-28, 7-29 subcultures, 3-3, 3-22 subpoena, 8-10 subpopulations, 3-10, 7-30, 8-7 substance abuse, iii severe, Substance Abuse and Mental Health Services Administration, 1-16 substance use, subtypes, alcoholic, 6-16 suburban areas, 2-33 Sudden Infant Death Syndrome (SIDS), 5-29 suggestion, 7-14 suicide; suicidal behavior, 2-21, 2-26, 3-9, 5-15, 5-29, 5-35 supervisor, 9-4 supply, efforts to control, 7-23 support systems, 7-25, 7-28, 7-31, 7-32, 9-18 surveys, 2-12 survival, behavior, survivors, 2-32, 7-31, 8-9 susceptibility, 5-47 sweat, 5-11, 5-19, 5-20 symbols, 3-5, 7-29 Symmetrel¨, 5-30
sympathetic, 5-2
“sympathomimetic,” 5-2, 5-36
symptoms, 2-26
synagogue, 3-11
Synanon, 1-20
synapses, 5-2, 5-4, 5-29, 5-32, 5-34,
synthetic drugs, 1-11
syphilis, 5-46, 9-18
syringes, 5-45
syrups, 5-33
T
tactile hallucinations, 5-29
target, 7-1, 7-17, 7-24, 7-32, 8-9 community, tavern, 1-13 taxes for alcohol and tobacco, 7-28, 8-4 tea, 1-9, 5-24, 5-40 teach-and-bleach programs, 8-14 teachers, 3-8, 3-13, 4-11 technology; technologies, Ted, case of, 9-3 teen deaths, leading cause of, 8-5 teen-age drinking, 9-21 teen-agers, 1-8, 1-10, 3-11, 4-2, 4-4, 4-10, 4-14, 5-30, 5-39, 6-12, 7-31, 8-5, 8-7, 9-19, 9-32 Temgesic¨, 5-10 temperament, 4-1, 4-9, 4-10 Temperance Movement, 1-1, 1-14 temperature-regulating center, 5-27 temporary insanity, 5-35 tensions in history of United States, 10-12 terminological map, 7-27 terminology, 4-1 “territory” disputes, 2-33 tertiary, or third-level prevention, 7-1, 7-5, 7-22 testicular atrophy, 5-41 testing, of pregnant women for HIV and hepatitis B, 5-45 testosterone, 5-19, 5-41 tetrahydoisoquinolines, 5-48 tetrahydrocannabinol (THC), 5-11, 5-37 thalamus, 5-6 therapeutic, agents, brief forms of, 1-8, 7-2, 7-5, 7-18, 7-21 THIQs, 5-48 third-level prevention, 7-1, 7-5 third-party, insurance, Thorazine¨, 5-6, 5-17, 5-43 thought process, 3-8, 4-2, 4-3, 4-8, 5-1 time in history, 1-9 time-frame, 7-1, 7-18 timing, 3-8 TIQs, 5-48 tissue and organ damage, 5-24 tobacco, 1-7, 1-9, 1-20, 2-2, 2-3, 2-4, 5-40, 7-25, 8-5, 8-13, 9-12,10-12 Tofranil¨, 5-45 tolerance, 5-1, 5-11, 5-14, 5-17, 5-20, 5-23, 5-29, 5-34 Tom, case of, 9-3, 9-4 toxic, 5-19, 5-23 traffic violations, 2-33 trafficking and use of drugs, 8-4 training, 8-12 insufficient, to practice refusing drugs in various circumstances, 7-26 tranquilizers, 1-20, 2-24, 2-31, 5-12, 5-17, 5-22, 9-16 transactional approach, 9-1, 9-3 transitions, 3-1, 3-4, 3-8, 4-10, 7-28, 9-10 transportation, 2-34, 7-31, 8-12 transsexuals, 3-19 trauma, 2-1, 2-24, 2-32, 2-33 treatment, 1-1, 1-8, 1-15, 1-18, 2-32, 2-33, 3-1, 3-2, 3-4, 3-5, 3-7, 3-10, 3-12, 3-13, 3-14, 3-16, 3-18, 3-20, 3-22, 3-23, 3-24, 3-29, 3-31, 3-32, 4-6, 4-7, 4-11, 4-14, 5-22, 5-23, 5-30, 5-32, 5-34, 5-42, 6-2, 6-17, 6-18, 7-4,7-15, 7-16, 7-22, 7-28, 7-37, 8-5, 8-9, 8-11, 9-3, 9-5, 9-6, 9-19, 10-6, 10-9, 10-11 and prevention, natural relationship between, 7-3 Trip Scrip, 5-43 troublemaker, 3-29 truancy, 9-32 trust, 7-14 Tuinal¨, 5-22
12-step approach, 7-12
21-28 day residential treatment programs, 7-6
twins, 5-47, 5-48
typologies, 6-1, 6-13, 6-16
U
underclass, 3-26
uninsured, number of, 10-8
unions, 3-4, 3-12
United Nations, 3-4
universal health insurance, 10-9
upper-class, 3-26
urban areas, 2-33
urination, excessive, 5-20
urine, 5-11, 5-12, 5-16, 5-19, 5-23, 5-25
drug screening, legal and ethical ramifications of, 8-11 users, “casual,” 7-28, 8-12
U. S. Army, 5-35
V
validation of treatment strategies, 8-3
validity of various modalities or philosophies, 7-14
Valium¨, 5-10, 5-11, 5-12, 5-13, 5-16, 5-17, 5-22, 5-23, 5-34, 9-13, 9-14, 9-30 value; values, 3-3, 3-6, 4-1, 4-3, 7-25, 9-1, 9-3, 9-25, 10-11 vasoconstrictive properties on mucous membranes, 5-24 vesicles, 5-4 victims of violence, 2-31 videotapes, 10-6 Vietnam war, 5-30, 6-7, 9-12, 9-13, 9-27, 9-28 vignettes, 1-9, 9-2, 9-7 violence, 2-27, 2-33, 3-12, 3-15, 3-20, 3-30, 4-13, 7-22, 7-31, 8-8, 8-13 increased risk of, during withdrawal, 8-10 violent behaviors and alcohol and other drug use, connection between, 2-31 violent crime, 8-13 associated with tobacco sales or use, 8-14 Vivarin¨, 5-40 vodka, 9-13, 9-27 Volstead Act, 1-12 vomiting, 5-20 vulnerability, 2-32, 3-8, 4-12, 5-1, 6-7, 9-10 drug-induced,
W
wakefulness, 5-24
War Against Poverty, 1-20
war zones, 2-33
warning labels, 2-3
warnings about sharing medications, 7-30
“wars on drugs,” 1-15
Washington, President George, 1-14
Washingtonian movement, 1-18
ways of handling high-risk pressures and temptations, 7-26 weakness, 5-29 weight lifters, 8-12 weight loss, 5-30 welfare of others, 2-27 well being, feeling of, 1-9 wets, 1-13 what we know about each other, 9-5 whiskey, 1-13 Whiskey Rebellion, 1-14 will, 7-12 willpower, 3-29 Wilson, Bill, 1-19; see also Alcoholics Anonymous wine, 1-14, 3-16, 3-21, 5-18, 5-24, 8-4, 9-30 wired, 9-18 wisdom, 10-7 withdrawal, 2-31, 5-14, 6-17, 5-20, 5-22, 5-23, 6-11 problems for hypnotics and sedatives, 5-23 Women for Sobriety, 7-17
women, 1-19, 2-31, 2-32, 2-33, 3-3, 3-20, 3-26, 4-2, 5-13, 6-17, 7-17, 7-30, 7-31, 8-9, 8-12, 9-4,
9-14, 9-18
women’s advocacy groups, 1-20
work groups, 7-29
working class, 3-2, 3-26
workplace, difficulties in the, 2-26
workplace assistance programs, 7-21
“works,” 5-45
worksite, 8-2, 7-16, 7-24
World War I, 1-12, 1-14
World War II, 5-30, 8-12, 10-7
X
“X” factor, 5-46, 5-47
Xanax¨, 5-22
Y
Yale School of Alcohol Studies, 1-15, 10-3
yellow fever, 2-5
youth, 7-24, 7-29, 8-5
Z
“zero-order” process, 5-12, 5-18

Source: http://www.vtcertificationboard.org/pdfs/FAODPINDEX.pdf

monomerpolymer.com

MATERIAL SAFETY DATA SHEET Section 1 - Chemical Product and Company Identification Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-monohydrochloride, monohydrate MONOMER-POLYMER & DAJAC LABORATORIES EMERGENCY TELEPHONE NUMBER (CHEMTREC): (800) 424-9300 or (703) 527-3887 Section 2 - Composition / Information on Ingredients CAS NUMBER HAZARDOUS COMPONENT Section 3 -

Erroneous analyses of interactions in neuroscience: a problem of significance

Erroneous analyses of interactions in neuroscience: a problem of significance Sander Nieuwenhuis1,2, Birte U Forstmann3 & Eric-Jan Wagenmakers3 In theory, a comparison of two experimental effects requires a That is, as famously noted by Rosnow and Rosenthal “surely, God statistical test on their difference. In practice, this comparison loves the 0.06 nearly as much as th

Copyright © 2011-2018 Health Abstracts